Your search for comorbidities returned 56 results

Rhythm control is not superior to rate control in patients with atrial fibrillation, and higher BMI appears to lower mortality risks.

Advisory board member, Ileana L. Piña, MD, shares her perspectives on the current state of heart failure, particularly treatment gaps between the genders.

During follow-up, CAD patients who were depressed were 83% more likely to die from any cause compared with patients who were not depressed.

Updated analyses and insights from the first cardiac resynchronization therapy-heart failure mortality/morbidity trial comparing defibrillator or pacemaker with pharmacologic therapy alone.

A panel formed from the American Heart Association and American Stroke Association identified best clinical practices and treatment gaps in post-stroke rehabilitation.

In an analysis of PARADIGM-HF participants, researchers discovered a possible all-cause mortality risk reduction in patients with heart failure who had received influenza vaccination.

With the release of the angiotensin receptor-neprilysin inhibitor (valsartan/sacubitril) and a sinoatrial node modulator (ivabradine), AHA/ACC/ESC have updated heart failure therapy guidelines.

The American Heart Association presents recommendations for managing pregnancy in women with congenital heart disease.

This week, we look at ideal cardiovascular health in elderly patients, how exercise my increase stroke survival, and a high-tech vest that monitors lung fluid in patients with heart failure.

Researchers found an upward trend in pregnancy-related spontaneous subarachnoid hemorrhage over a span of 12 years.